Status:

COMPLETED

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Lead Sponsor:

Yonsei University

Conditions:

Mitral Valvular Heart Disease

Eligibility:

All Genders

Phase:

NA

Brief Summary

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Eligibility Criteria

Inclusion

  • Mitral valvular heart disease

Exclusion

  • Status of Infection
  • Re-operation
  • Liver failure
  • Renal disease
  • Administration of steroid

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT00978588

Start Date

February 1 2008

End Date

August 1 2009

Last Update

February 3 2012

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass | DecenTrialz